Gritstone Oncology Stock News

Gritstone bio (GRTS) said the first patient was enrolled in a phase 2/3 GRANITE-CRC-1L trial to evaluate the individualized neoantigen vaccine GRANITE in combination with immune

It's not too late to invest in this dynamic area.

It's not too late to invest in this dynamic area.

In what looks like an extreme case of sell the news, shares of Gritstone bio (GRTS) cratered by 42% in Tuesdays session following the release of positive trial d

Investors need to pay close attention to Gritstone (GRTS) stock based on the movements in the options market lately.

EMERYVILLE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immun

EMERYVILLE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunot

Gritstone bio Inc. (NASDAQ:GRTS) shares, rose in value on Thursday, 12/16/21, with the stock price down by -0.50% to the previous days close as strong demand from buyers drove the stock to $12.04. Actively observing the price movement in the last trading, the stock closed the session at $12.10, falling within a range of $11.82 Is Gritstone bio Inc. (NASDAQ: GRTS) A Stock A New Investor Should Consider Now? Read More »

-- Clare Fisher, accomplished corporate and business development executive and current svp of business development and mergers & acquisitions at BeiGene, will join the Board effective January 1, 2022

-- Clare Fisher, accomplished corporate and business development executive and current svp of business development and mergers & acquisitions at BeiGene, will join the Board effective January 1, 2022 -- -- Judith J. Li, partner at Lilly Asia Ventures, will depart the Board effective January 1, 2022 --

The trading price of Gritstone bio Inc. (NASDAQ:GRTS) closed lower on Monday, December 13, closing at $11.88, -1.49% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

EMERYVILLE, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immun

They may deliver major gains down the road.

They may deliver major gains down the road.